Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of 64Cu-DOTA-Alendronate PET Imaging for Localization and Characterization of Breast Calcifications

NCT03542695 is registered in ClinicalTrials.gov with City of Hope Medical Center as lead sponsor.

NCT NCT03542695
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03542695 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of 64Cu-DOTA-Alendronate PET Imaging for Localization and Characterization of Breast Calcifications
Lead sponsor
City of Hope Medical Center
Phase
Phase 1
Overall status
Completed
Start date
November 3, 2021
Completion date
May 31, 2024
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast carcinoma, calcification